title: The effect of porcine Orexin A on insulin plasma concentrations in pigs.
abstract: Orexin A is a member of a wider family of orexigenic neuropeptides that have been recently discovered. They are produced by a small group of neurons located in the area of the brain, round the nucleus of the fornix (posterior hypothalamus), in the paraventricular nucleus, the dorsomedial nucleus, the ventromedial hypothalamus, as well as in the lateral hypothalamic region; these are sites that are known to be involved in regulating feeding in mammals. Orexin A is a neuropeptide, which is involved in appetite regulation and energy homeostasis. An intracerebroventricular (i.c.v.) injection of Orexin A in the brain of rats causes an impressive increase in food consumption. In addition, a subcutaneous or intravenous (IV) injection of Orexin A produces changes on insulin plasma concentrations in rats. Recent research suggests that Orexin A is also involved in regulating many other physiological functions. In this study, we examined the potential effects of the central administration of porcine Orexin A on insulin plasma concentrations in pigs, and whether these changes are connected with the possible effect of the neuropeptide on the enteroinsular axis.
authors.affiliation: 3rd Surgical Clinic, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece. pan@med.auth.gr
authors.forename: P
authors.initials: P
authors.lastname: Papakonstantinou
authors.forename: N
authors.initials: N
authors.lastname: Tziris
authors.forename: I
authors.initials: I
authors.lastname: Kesisoglou
authors.forename: A
authors.initials: A
authors.lastname: Gotzamani-Psarrakou
authors.forename: Chr
authors.initials: C
authors.lastname: Tsonidis
authors.forename: M N
authors.initials: MN
authors.lastname: Patsikas
authors.forename: L G
authors.initials: LG
authors.lastname: Papazoglou
mesh_terms: D000818:Animals; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood*; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000008:administration & dosage / Q000494:pharmacology; D000068797:Orexins; D013552:Swine
chemical_list: D007328:Insulin; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D000068797:Orexins; D005947:Glucose